Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease — Stella

Home/Parkinson Disease/

View on ClinicalTrials.gov

Recruiting

Back to Parkinson Disease trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Michigan, Ann Arbor, Michigan

Key details

Phase

Safety & dosing

Sponsor

Vikas Kotagal

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~102 participants

Started

April 2025

Primary completion

January 2029

Age range

45 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.